no news in this list.


TRION Research is an independent research organization offering specialized preclinical and clinical services to the biopharmaceutical industry, from initial drug design through to clinical studies.

Originally founded in 1998 as an independent entity by Horst Lindhofer, we have assisted in the preclinical and clinical development of all Triomab® antibodies that are under development or on the market today, including that of Removab®, the first bispecific, trifunctional antibody on the market worldwide. We have also generated all further candidates of the Triomab® familiy. Over the years, we have gathered extensive experience – not only in the fields of tumor immunology, immunomonitoring and assay development, but also in the management of sample logistics and data handling according to international regulatory requirements.